201Tl-chloride | 99mTc-MIBI | 99mTc-tetrofosmin | 18F-FDG | 82Rb | 13N-NH3 | 99mTc-labeled RBCs | 15O-H2O | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICRP (6) | Thomas et al. (7) | ICRP (6) | RIDIC (8) | ICRP (6) | RIDIC (8) | MIRD (15) | ICRP (6) | ICRP (6) | RIDIC (8) | ICRP (6) | RIDIC (8) | RIDIC (8) | ICRP (6) | RIDIC (8) | ICRP (6) | |||||
Parameter | Resting | Exercise | Resting | Exercise | Resting | Exercise | In vitro | In vivo | ||||||||||||
Effective dose/unit of administered activity (mSv/MBq) | 2.2E−01 | 1.6E−01 | 9.0E−03 | 7.9E−03 | 1.3E−02 | 9.5E−03 | 7.6E−03 | 7.0E−03 | 3.0E−02 | 1.6E−02 | 1.9E−02 | 3.4E−03 | 7.9E−04 | 2.0E−03 | 2.0E−03 | 6.1–03 | 6.1–03 | 7.0E−03 | 1.1E−03 | 9.3E−04 |
Assumed activity/per study, MBq (mCi) | 74 (2) | 74 (2) | 740 (20) | 740 (20) | 740 (20) | 740 (20) | 740 (20) | 740 (20) | 370 (10) | 370 (10) | 370 (10) | 1,110 (30) | 1,110 (30) | 740 (20) | 740 (20) | 740 (20) | 740 (20) | 740 (20) | 2,220 (60) | 2,220 (60) |
Effective dose/study (mSv) | 16 | 12 | 6.7 | 5.8 | 9.6 | 7.0 | 5.6 | 5.2 | 11.1 | 5.9 | 7.0 | 3.8 | 0.88 | 1.5 | 1.5 | 4.5 | 4.5 | 5.2 | 2.4 | 2.1 |